Official UK procurement notice
Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionThe award is for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis.
Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887.
Please see section II.2.4 for detailed description of the procurement.
CPV: Medical consumables · Other therapeutic products · Repair and maintenance services of medical equipment
The lotProcurement structure
single lot · no lot value publishedLot #1The Therapeutic Apheresis Services (TAS) function operates within the Clinical…Awarded
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection.
The requirement for this procurement was for the supply of consumables and maintenance of the existing ART Universal machines. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887.
As a result of the tender, a Framework Agreement for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis for a period of 2 years with two 1-year options to extend has been awarded to Fresenius Medical Care (UK) Ltd.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 11 Aug 2021, 16:14 BST
- Last source update
- 11 Aug 2021, 16:14 BST
- Authority reference
NHSBT1498 / C39526- FTS notice number
2021/S 000-019494- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02d395Find a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Fresenius Medical Care (UK) Limited | £99,500 † | — | Awarded |
Contracts
Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis · Fresenius Medical Care (UK) Limited
- Signed
- 1 Aug 2021
- Value
- £99,500
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS Blood and TransplantReview body
Bidders & participating suppliers
1 commercial party on the notice- Fresenius Medical Care (UK) LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.